We recently published a list of the 15 Best High-Yield Dividend Stocks for 2025 and Beyond. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other best ...

Here is why Pfizer can't seem to get off the mat and whether it's worth buying the dip on today. I won't rehash Pfizer's pandemic journey too much. The company developed and sold a vaccine (Comirnaty) ...

With that in mind, let's consider two high-yield dividend stocks worth investing in: Pfizer (NYSE: PFE) and Medical ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Pfizer's stock ... offers a 6.3% forward dividend yield. Despite a positive Q3 earnings surprise, profitability remains weaker than pre-pandemic levels, and valuation analysis shows the stock ...

Income investors have liked Pfizer (NYSE: PFE) for years. Wondering if Pfizer's 7.6% dividend yield is sustainable? Pfizer's management remains confident about the company's ability to fund the ...

Of the 22 guru strategies we follow, PFE rates highest using our Shareholder Yield Investor model based on the published strategy of Meb Faber. This strategy looks for companies returning cash to ...

Pfizer's stock appears undervalued with ... we also should not avoid a stock simply because of a high dividend yield – such an analysis would probably be too simplistic. One news item that ...

Trading for $23.03, PFE stock is down 13.5% year-to-date and 17% in 12 months. It has a dividend yield of 7.47%, which makes it worth an addition to your portfolio. It has increased dividends for ...

We recently published a list of the 15 Best High-Yield Dividend Stocks for 2025 and Beyond. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other best ...